Business Description
Noile-Immune Biotech Inc
ISIN : JP3759560000
Total Employee Number:
28Description
Noile-Immune Biotech Inc is engaged in the development of CAR-T cell therapy for solid cancers using its proprietary technology. The company's development pipeline and collaborative projects with other companies include different product candidates such as NIB102, NIB103, NIB104, ADAP01, AUTL01, etc. It operates in a single segment, the cancer immunotherapy drug discovery business.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.98 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 41.47 | |||||
Beneish M-Score | -3.77 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -80.7 | |||||
3-Year EBITDA Growth Rate | -89.3 | |||||
3-Year EPS without NRI Growth Rate | -22.9 | |||||
3-Year FCF Growth Rate | -85.2 | |||||
3-Year Book Growth Rate | -4.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 588.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 81.41 | |||||
9-Day RSI | 72.12 | |||||
14-Day RSI | 63.61 | |||||
3-1 Month Momentum % | -20.67 | |||||
6-1 Month Momentum % | -18.49 | |||||
12-1 Month Momentum % | -32.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 62.52 | |||||
Quick Ratio | 62.49 | |||||
Cash Ratio | 61.32 | |||||
Days Sales Outstanding | 4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -17404.34 | |||||
Net Margin % | -15163.18 | |||||
EBITDA Margin % | -17404.34 | |||||
FCF Margin % | -35101.21 | |||||
OCF Margin % | -35101.21 | |||||
ROE % | -7.88 | |||||
ROA % | -7.73 | |||||
ROIC % | -549.46 | |||||
3-Year ROIIC % | 742.11 | |||||
ROC (Joel Greenblatt) % | -5927.29 | |||||
ROCE % | -9.03 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2775.51 | |||||
PB Ratio | 1.56 | |||||
Price-to-Tangible-Book | 1.56 | |||||
EV-to-EBIT | -5.75 | |||||
EV-to-EBITDA | -5.75 | |||||
EV-to-Revenue | 1001.15 | |||||
EV-to-FCF | -2.45 | |||||
Price-to-GF-Value | 31.34 | |||||
| Price-to-Net-Current-Asset-Value | 1.57 | |||||
| Price-to-Net-Cash | 1.6 | |||||
Earnings Yield (Greenblatt) % | -17.38 | |||||
FCF Yield % | -12.78 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Noile-Immune Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 2.143 | ||
| EPS (TTM) (円) | -7.5 | ||
| Beta | 0.2832 | ||
| 3-Year Sharpe Ratio | -0.77 | ||
| 3-Year Sortino Ratio | -1.03 | ||
| Volatility % | 35.49 | ||
| 14-Day RSI | 63.61 | ||
| 14-Day ATR (円) | 4.863819 | ||
| 20-Day SMA (円) | 122.7 | ||
| 12-1 Month Momentum % | -32.39 | ||
| 52-Week Range (円) | 114 - 217 | ||
| Shares Outstanding (Mil) | 43.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Noile-Immune Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Noile-Immune Biotech Inc Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Noile-Immune Biotech Inc Frequently Asked Questions
What is Noile-Immune Biotech Inc(TSE:4893)'s stock price today?
The current price of TSE:4893 is 円136.00. The 52 week high of TSE:4893 is 円217.00 and 52 week low is 円114.00.
When is next earnings date of Noile-Immune Biotech Inc(TSE:4893)?
The next earnings date of Noile-Immune Biotech Inc(TSE:4893) is .
Does Noile-Immune Biotech Inc(TSE:4893) pay dividends? If so, how much?
Noile-Immune Biotech Inc(TSE:4893) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Noile-Immune Biotech Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers